|[September 04, 2014]
Agere CEO to Present Innovations in Formulating for Oral Bioavailability
BEND, Ore. --(Business Wire)--
Agere Pharmaceuticals, Inc., a leading innovator in oral bioavailability
solutions and specializing in amorphous solid dispersions announced
today that it will present at the Catalent interactive training session
this month in Somerset, New Jersey. The agenda features other renowned
experts including those from Catalent Pharma Solutions, St. John's
University and the University of Mississippi.
CONFERENCE: Advances in Drug Delivery - Optimal
Bioavailability and Controlled Release for Improved Outcomes
When: Wednesday, September 10th, 2014 (8:30 AM - 4:30
Where: The Palace, Somerset, NJ
Agenda & Free Registration: Please follow the link
to the event page
For more information about this event or to schedule a meeting with
Agere, please contact Agere at firstname.lastname@example.org.
Agere is a leading CDMO focused on improving the oral bioavailability of
insoluble active pharmaceutical ingredients (APIs). The company supports
clients from screening to identify the optimal solubilization
technology, formulation design and development, and cGMP manufacturing
for Phase I through Phase IIb clinical trial materials. All services
follow industry best practices guidelines, and are delivered on a
fee-for-service basis. Agere's proprietary formulation design platform,
Quadrant 2™, enables the company to deliver a customized solution for
every compound to serve each individual client's requirements. The
company is located in Bend, OR. For information: www.agerepharma.com.
For more details, visit www.drugdeliveryinstitute.com.
Agere Pharmaceuticals and Quadrant 2 are trademarks owned by
Agere Pharmaceuticals, Inc.
[ Back To TMCnet.com's Homepage ]